Clinical Trial: A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07441486) titled 'A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer' on June 11, 2025.

Brief Summary: Objective: To explore the curative effect and safty of Changchun Ruibin metronomic chemotherapy combined with endistat in the treatment of HR positive HER2 negative advanced breast carcinoma.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: DRUG: Entinostat

Entinostat will be administered according to the study protocol.

DRUG: Oral Paclitaxel

Oral paclitaxel will be administered according to th...